Cargando…
Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma
Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive cancer types in China. In recent years, progress has been made in various types of cancer genomics including ESCC. However, the clinical significance of genomic variation of ESCC remains poorly defined. In the present study, gen...
Autores principales: | Zhang, Ling, Niu, Xia, Bi, Yanghui, Cui, Heyang, Li, Hongyi, Cheng, Xiaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493273/ https://www.ncbi.nlm.nih.gov/pubmed/32924793 http://dx.doi.org/10.1177/1533033820948060 |
Ejemplares similares
-
TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2
por: Zhang, Ling, et al.
Publicado: (2020) -
CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
por: Li, Hongyi, et al.
Publicado: (2021) -
EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019) -
FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma
por: Hu, Xiaoling, et al.
Publicado: (2018) -
The macro-evolutionary events in esophageal squamous cell carcinoma
por: Yang, Bin, et al.
Publicado: (2017)